MARKET WIRE NEWS

Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-07 19:34:09 ET

Akebia Therapeutics, Inc. (AKBA)

Q2 2025 Earnings Conference Call

August 07, 2025 08:00 AM ET

Company Participants

Erik John Ostrowski - Chief Business Officer, Senior VP, CFO & Treasurer

John P. Butler - CEO, President & Director

Mercedes Carrasco - Senior Director of Investor & Corporate Communications

Nicholas Grund - Senior VP & Chief Commercial Officer

Conference Call Participants

Julian Reed Harrison - BTIG, LLC, Research Division

Mazahir Lukman Alimohamed - Leerink Partners LLC, Research Division

Roger Song - Jefferies LLC, Research Division

Presentation

Operator

Good day and thank you for standing by. Welcome to the Akebia Second Quarter 2025 Financial Results. [Operator Instructions] Please be advised that today's call is being recorded....

Read the full article on Seeking Alpha

For further details see:

Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript
Akebia Therapeutics Inc.

NASDAQ: AKBA

AKBA Trading

0.73% G/L:

$1.385 Last:

1,435,210 Volume:

$1.40 Open:

mwn-link-x Ad 300

AKBA Latest News

February 26, 2026 02:25:40 pm
Akebia (AKBA) Q4 2025 Earnings Call Transcript

AKBA Stock Data

$399,375,819
257,405,013
0.93%
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App